The pathogenic N650K variant in the GluN1 subunit regulates the trafficking, conductance, and pharmacological properties of NMDA receptors-Reference-Cited by-同舟云学术

The pathogenic N650K variant in the GluN1 subunit regulates the trafficking, conductance, and pharmacological properties of NMDA receptors

Published:2023-01 Issue: Volume:222 Page:109297
ISSN:0028-3908
Container-title:Neuropharmacology
language:en
Short-container-title:Neuropharmacology

Author:

Kolcheva Marharyta,Ladislav Marek,Netolicky Jakub,Kortus Stepan,Rehakova Kristyna,Krausova Barbora Hrcka,Hemelikova Katarina,Misiachna Anna,Kadkova Anna,Klima Martin,Chalupska Dominika,Horak Martin

Funder

Grantová Agentura, Univerzita Karlova

European Commission

Ministerstvo Školství, Mládeže a Tělovýchovy

Grantová Agentura České Republiky

Charles University

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Pharmacology

Reference69 articles.

1. Reduced expression of hippocampal GluN2A-NMDAR increases seizure susceptibility and causes deficits in contextual memory;Acutain;Front. Neurosci.,2021

2. NMDAR channel segments forming the extracellular vestibule inferred from the accessibility of substituted cysteines;Beck;Neuron,1999

3. The GluN3 subunit regulates ion selectivity within native N-methyl-d-aspartate receptors;Beesley;IBRO Rep,2020

4. Antidepressant effects of ketamine in depressed patients;Berman;Biol. Psychiatr.,2000

5. Trapping channel block of NMDA-activated responses by amantadine and memantine;Blanpied;J. Neurophysiol.,1997

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potent and reversible open-channel blocker of NMDA receptor derived from dizocilpine with enhanced membrane-to-channel inhibition;Biomedicine & Pharmacotherapy;2024-09

2. Disease-Associated Variants in GRIN1, GRIN2A and GRIN2B genes: Insights into NMDA Receptor Structure, Function, and Pathophysiology;Physiological Research;2024-08-31

3. Dizocilpine derivatives with neuroprotective effect lacking the psychomimetic side effects;2024-06-17

4. NMDA Receptor Antagonists: Emerging Insights into Molecular Mechanisms and Clinical Applications in Neurological Disorders;Pharmaceuticals;2024-05-15

5. Potent and reversible open-channel blocker of NMDA receptor derived from dizocilpine with enhanced membrane-to-channel inhibition;2024-04-17